News | March 30, 2024
Aragen operationalizes first phase of its US$ 30 million Biologics manufacturing facility in India
Executes the first project for developing and manufacturing a novel anticancer mAb
Executes the first project for developing and manufacturing a novel anticancer mAb
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
New Board of Directors and management team at Suven Pharma also appointed
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)